首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   50561篇
  免费   3208篇
  国内免费   284篇
耳鼻咽喉   696篇
儿科学   1429篇
妇产科学   1212篇
基础医学   7272篇
口腔科学   853篇
临床医学   7021篇
内科学   9353篇
皮肤病学   1060篇
神经病学   4473篇
特种医学   1543篇
外科学   5377篇
综合类   508篇
现状与发展   1篇
一般理论   57篇
预防医学   5044篇
眼科学   943篇
药学   3231篇
中国医学   235篇
肿瘤学   3745篇
  2023年   244篇
  2022年   554篇
  2021年   1253篇
  2020年   696篇
  2019年   1134篇
  2018年   1357篇
  2017年   942篇
  2016年   1142篇
  2015年   1549篇
  2014年   2030篇
  2013年   2731篇
  2012年   3994篇
  2011年   4026篇
  2010年   2308篇
  2009年   1894篇
  2008年   3407篇
  2007年   3374篇
  2006年   3354篇
  2005年   3049篇
  2004年   2830篇
  2003年   2648篇
  2002年   2488篇
  2001年   476篇
  2000年   352篇
  1999年   454篇
  1998年   498篇
  1997年   434篇
  1996年   382篇
  1995年   331篇
  1994年   311篇
  1993年   292篇
  1992年   260篇
  1991年   239篇
  1990年   216篇
  1989年   194篇
  1988年   175篇
  1987年   211篇
  1986年   156篇
  1985年   168篇
  1984年   193篇
  1983年   192篇
  1982年   221篇
  1981年   188篇
  1980年   173篇
  1979年   115篇
  1978年   110篇
  1977年   88篇
  1976年   71篇
  1975年   64篇
  1974年   80篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Introduction: The landscape of poly (ADP-ribose) polymerase (PARP) inhibition in ovarian cancer is rapidly evolving and becoming increasingly complex. Ovarian cancer is leading therapeutic innovation by providing the proof of concept for DNA repair as a target. Three different PARP inhibitors have now received approvals in the US and Europe in different indications. Subtle but crucial differences can be found among the licensed indications for each PARP inhibitor in terms of histology, type of BRCA mutation (germline and/or somatic), number of prior lines of chemotherapy and whether the indication is in the treatment or maintenance settings.

Areas covered: We review the latest clinical data regarding the PARP inhibitor rucaparib in ovarian cancer, provide an update on the evolving landscape of PARP inhibition in ovarian cancer, and summarize avenues of ongoing and future research.

Expert opinion: All eligible patients should be offered a PARP inhibitor. SOLO1 trial results demonstrated an unprecedented benefit maintenance with PARP inhibitors in first line. Results from trials evaluating PARP inhibitors as maintenance in first line regardless of BRCA status and from trials evaluating combinatorial strategies are eagerly awaited.  相似文献   

3.
Direct peroral cholangioscopy (POC) using an ultra‐slim upper endoscope is one modality of POC for intraductal endoscopic evaluation and treatment of the bile duct. Choledochoduodenostomy (CDS) is one modality of biliary bypass surgery that provides a new route to the bile duct. We carried out direct POC using an ultra‐slim upper endoscope without the use of accessories in 10 patients (four sump syndromes, three bile duct strictures and three intrahepatic duct stones) previously undergoing surgical CDS. Direct POC was successful in all patients. The use of an intraductal balloon catheter was required in one patient for advancement of the endoscope into the bile duct. Distal bile ducts with sump syndromes were cleared using baskets and water irrigation under direct POC. Cholangiocarcinoma was diagnosed in one patient with hilar bile duct stricture after cholangioscopic evaluation and a targeting forceps biopsy under direct POC. Intrahepatic duct stones were successfully extracted after intraductal fragmentation under direct POC. Oozing bleeding occurred during intraductal lithotripsy but stopped spontaneously. Direct POC using an ultra‐slim upper endoscope without the assistance of accessories can easily be carried out in patients undergoing CDS.  相似文献   
4.
5.
6.
7.
8.
9.
10.

Background

The purpose of this study was to compare the outcomes of trauma patients who were injured in a motor vehicle crash and tested positive for alcohol upon hospital arrival versus those who tested negative.

Methods

Study data came from the US National Trauma Data Bank (2007–2010). Any blood alcohol concentration (BAC) found at or above the legal limit (≥0.08?g/dL) was considered “alcohol positive”, and if no alcohol was identified through testing, the patient was considered “alcohol negative”. Patients’ demographics including age >?=?14, race, gender, drug test results, systolic blood pressure, heart rate, injury severity score (ISS), and Glasgow Coma Scale (GCS) were included in the study. Propensity score and exact pair matching were performed between the groups using baseline characteristics.

Results

From a total of 88,794 patients, 30.9% tested positive and 69.1% tested negative for alcohol. There were significant differences found between the groups regarding age, gender, race, and GCS (all p?<?0.001) as well as a significantly higher in-hospital mortality rate (3.5% vs. 2.7%, p?<?0.001) and median time to patient expiration (4 vs. 3 days, p?<?0.001) in the alcohol negative group. After running both matching scenarios, there was no evidence of a significant difference seen in the rates of in-hospital mortality or the median time to patient expiration between the alcohol groups in either matched comparison.

Conclusion

Patients who tested positive for alcohol following a traumatic motor vehicle crash showed no significant increase in in-hospital mortality or time to expiration when compared to propensity score and exact matched patients who tested negative for alcohol.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号